C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 115 filers reported holding C4 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,607,935 | -19.8% | 864,481 | +18.6% | 0.01% | -16.7% |
| Q2 2023 | $2,004,588 | -11.8% | 728,941 | +0.7% | 0.01% | -14.3% |
| Q1 2023 | $2,272,421 | -47.1% | 723,701 | -0.7% | 0.01% | -51.7% |
| Q4 2022 | $4,299,159 | -33.7% | 728,671 | -1.4% | 0.03% | -43.1% |
| Q3 2022 | $6,481,000 | +61.5% | 738,993 | +38.8% | 0.05% | +64.5% |
| Q2 2022 | $4,014,000 | +353.0% | 532,420 | +2174.0% | 0.03% | +416.7% |
| Q2 2021 | $886,000 | – | 23,413 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |